2024 Q1 Form 10-K Financial Statement

#000121390024022183 Filed on March 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.046M $1.205M $3.862M
YoY Change 26.02% 50.06% -1.63%
Cost Of Revenue $2.761M $3.346M $12.74M
YoY Change -8.67% 13.89% 433.4%
Gross Profit -$1.715M -$2.141M -$8.881M
YoY Change -21.8% 0.28% -677.81%
Gross Profit Margin -163.96% -177.68% -229.96%
Selling, General & Admin $8.446M $11.60M $30.32M
YoY Change 39.51% 64.52% -17.88%
% of Gross Profit
Research & Development $4.670M $4.924M $19.50M
YoY Change 2.01% 13.61% 14.33%
% of Gross Profit
Depreciation & Amortization $1.319M $1.262M $4.821M
YoY Change 17.24% 24.46% 31.33%
% of Gross Profit
Operating Expenses $13.12M $17.79M $54.65M
YoY Change -11.26% 43.45% -21.33%
Operating Profit -$16.15M -$19.93M -$63.53M
YoY Change 15.77% 37.11% -3.06%
Interest Expense -$2.208M -$2.050M -$3.664M
YoY Change -570.79% -549.56% -506.66%
% of Operating Profit
Other Income/Expense, Net -$72.00K $5.645M -$4.321M
YoY Change -11.11% 274.34% 2248.37%
Pretax Income -$31.60M -$16.33M -$71.51M
YoY Change 92.68% 29.93% 78.14%
Income Tax $44.00K $62.00K $221.0K
% Of Pretax Income
Net Earnings -$31.60M -$16.40M -$71.74M
YoY Change 93.87% 31.15% 78.89%
Net Earnings / Revenue -3021.03% -1360.66% -1857.46%
Basic Earnings Per Share -$0.28 -$0.66
Diluted Earnings Per Share -$0.28 -$0.15 -$0.66
COMMON SHARES
Basic Shares Outstanding 111.2M shares 110.1M shares 108.0M shares
Diluted Shares Outstanding 111.1K shares 108.0M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.24M $85.83M $85.83M
YoY Change 69.32% 54.8% 54.8%
Cash & Equivalents $73.32M $81.88M $81.88M
Short-Term Investments $5.922M $3.954M $3.954M
Other Short-Term Assets $16.05M $3.056M $3.056M
YoY Change 341.62% -14.54% -14.54%
Inventory
Prepaid Expenses
Receivables $1.496M $2.332M $2.332M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $96.79M $91.22M $91.22M
YoY Change 87.49% 49.08% 49.08%
LONG-TERM ASSETS
Property, Plant & Equipment $39.33M $40.83M $40.83M
YoY Change 11.61% 112.87% 24.11%
Goodwill $17.58M $17.98M
YoY Change -1.35% 2.77%
Intangibles $10.36M $10.63M
YoY Change
Long-Term Investments $665.0K
YoY Change
Other Assets $1.572M $1.508M $1.508M
YoY Change -9.24% -16.73% -16.73%
Total Long-Term Assets $68.84M $70.94M $70.94M
YoY Change 5.28% 13.32% 13.32%
TOTAL ASSETS
Total Short-Term Assets $96.79M $91.22M $91.22M
Total Long-Term Assets $68.84M $70.94M $70.94M
Total Assets $165.6M $162.2M $162.2M
YoY Change 41.55% 31.0% 31.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.269M $391.0K $391.0K
YoY Change 93.45% -61.63% -61.63%
Accrued Expenses $10.30M $9.115M $9.115M
YoY Change 38.57% 17.26% 17.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.14M $9.803M $9.803M
YoY Change 196.23% 10.31% 10.31%
LONG-TERM LIABILITIES
Long-Term Debt $49.89M $48.45M $48.45M
YoY Change
Other Long-Term Liabilities $1.596M $23.81M $23.81M
YoY Change -0.25% 115.75% 115.75%
Total Long-Term Liabilities $51.49M $72.26M $72.26M
YoY Change 3117.88% 554.7% 554.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.14M $9.803M $9.803M
Total Long-Term Liabilities $51.49M $72.26M $72.26M
Total Liabilities $108.4M $83.42M $83.42M
YoY Change 342.42% 318.71% 250.95%
SHAREHOLDERS EQUITY
Retained Earnings -$791.8M -$760.2M
YoY Change 12.34% 10.42%
Common Stock $846.7M $12.00K
YoY Change 6.95% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $665.0K $665.0K
YoY Change 16525.0% 16525.0%
Treasury Stock Shares
Shareholders Equity $55.91M $78.73M $78.73M
YoY Change
Total Liabilities & Shareholders Equity $165.6M $162.2M $162.2M
YoY Change 41.55% 31.0% 31.0%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$31.60M -$16.40M -$71.74M
YoY Change 93.87% 31.15% 78.89%
Depreciation, Depletion And Amortization $1.319M $1.262M $4.821M
YoY Change 17.24% 24.46% 31.33%
Cash From Operating Activities -$7.000M -$10.83M -$35.44M
YoY Change -5.41% -9.04% -4.47%
INVESTING ACTIVITIES
Capital Expenditures $32.00K $485.0K $3.734M
YoY Change -96.26% -69.26% 25.98%
Acquisitions
YoY Change
Other Investing Activities -$1.918M $3.053M $4.808M
YoY Change -136.79% -206.71% -139.54%
Cash From Investing Activities -$2.113M $2.568M $1.074M
YoY Change -152.61% -157.85% -106.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $955.0K
YoY Change -31933.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $516.0K -21.00K 68.98M
YoY Change -51700.0% 2000.0% 160327.91%
NET CHANGE
Cash From Operating Activities -$7.000M -10.83M -35.44M
Cash From Investing Activities -$2.113M 2.568M 1.074M
Cash From Financing Activities $516.0K -21.00K 68.98M
Net Change In Cash -$8.561M -8.286M 34.62M
YoY Change 150.54% -49.32% -165.51%
FREE CASH FLOW
Cash From Operating Activities -$7.000M -$10.83M -$35.44M
Capital Expenditures $32.00K $485.0K $3.734M
Free Cash Flow -$7.032M -$11.32M -$39.17M
YoY Change -14.83% -16.09% -2.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101029000 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001865631
CY2023 nn Indefinite Lived License Agreements With Federal Government Renewal Term
IndefiniteLivedLicenseAgreementsWithFederalGovernmentRenewalTerm
P10Y
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40985
CY2023 dei Entity Registrant Name
EntityRegistrantName
NextNav Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0854654
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1775 Tysons Blvd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
McLean
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22102
CY2023 dei City Area Code
CityAreaCode
(800)
CY2023 dei Local Phone Number
LocalPhoneNumber
775-0982
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2023 dei Trading Symbol
TradingSymbol
NN
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
215791582 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111189983 shares
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Tysons, Virginia
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
81878000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
47230000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
3954000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
8216000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2332000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2168000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3056000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3576000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
91220000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
61190000 usd
CY2023Q4 nn Network Under Construction
NetworkUnderConstruction
1676000 usd
CY2022Q4 nn Network Under Construction
NetworkUnderConstruction
3574000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9724000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5971000 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
19885000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
19180000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19267000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10143000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
17977000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17493000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10625000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10397000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1508000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1811000 usd
CY2023Q4 us-gaap Assets
Assets
162158000 usd
CY2022Q4 us-gaap Assets
Assets
123788000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
391000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1019000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5241000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2523000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2532000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
297000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
95000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9803000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8887000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7053000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4200000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5290000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1614000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1547000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48447000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2023Q4 us-gaap Liabilities
Liabilities
82062000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19924000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111260257 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106418442 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111132222 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106417265 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
837416000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
787130000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2198000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1371000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-760227000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-688492000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
128035 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1177 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
665000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
78734000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
100017000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1362000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
3847000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162158000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123788000 usd
CY2023 us-gaap Revenues
Revenues
3862000 usd
CY2022 us-gaap Revenues
Revenues
3926000 usd
CY2023 nn Cost Of Goods And Service Excluding Depreciation And Amortization
CostOfGoodsAndServiceExcludingDepreciationAndAmortization
12743000 usd
CY2022 nn Cost Of Goods And Service Excluding Depreciation And Amortization
CostOfGoodsAndServiceExcludingDepreciationAndAmortization
11806000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19503000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17059000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30324000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36926000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4821000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3671000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
67391000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
69462000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-63529000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-65536000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3664000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
901000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24675000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-220000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-184000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-71514000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40144000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-71735000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-40116000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
827000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1492000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70908000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38624000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71735000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-40116000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71735000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40116000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107972000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107972000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101029000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101029000 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99442000 usd
CY2022 nn Stock Issued During Period Value Restricted Stock Award Vested
StockIssuedDuringPeriodValueRestrictedStockAwardVested
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
56000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25252000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-40116000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1492000 usd
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000 usd
CY2022 nn Issuance Of Shares Related To Business Combination
IssuanceOfSharesRelatedToBusinessCombination
17736000 usd
CY2022 nn Stock Redeemed Or Called Non Controlling Interests During Period Value
StockRedeemedOrCalledNonControllingInterestsDuringPeriodValue
-6000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103864000 usd
CY2023 nn Stock Issued During Period Value Restricted Stock Award Vested
StockIssuedDuringPeriodValueRestrictedStockAwardVested
usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
73000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
882000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20207000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
22843000 usd
CY2023 nn Stock Issued During Period Value Interest Payment
StockIssuedDuringPeriodValueInterestPayment
1888000 usd
CY2023 nn Stock Redeemed Or Called Non Controlling Interests During Period Value
StockRedeemedOrCalledNonControllingInterestsDuringPeriodValue
-660000 usd
CY2023 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
1248000 usd
CY2023 nn Stock Redeemed Or Called During Period Value Settlement Of Employee Receivables
StockRedeemedOrCalledDuringPeriodValueSettlementOfEmployeeReceivables
661000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71735000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
827000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80096000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-71735000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-40116000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4821000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3671000 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
21838000 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
26501000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4101000 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
24675000 usd
CY2023 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
546000 usd
CY2022 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
72000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-191000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-230000 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
66000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
56000 usd
CY2023 nn Amortization Of Debt Issuance Costs And Discount
AmortizationOfDebtIssuanceCostsAndDiscount
3151000 usd
CY2022 nn Amortization Of Debt Issuance Costs And Discount
AmortizationOfDebtIssuanceCostsAndDiscount
usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
164000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
428000 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-537000 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-593000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-119000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-161000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-627000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
486000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
202000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1537000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1884000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2501000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
722000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
536000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35440000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37095000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2751000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2964000 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1125000 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
37441000 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13644000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
42249000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5500000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2890000 usd
CY2023 nn Purchase Of Internal Use Software
PurchaseOfInternalUseSoftware
983000 usd
CY2022 nn Purchase Of Internal Use Software
PurchaseOfInternalUseSoftware
613000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1074000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15736000 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
70000000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1861000 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2023 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
110000 usd
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
17000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
73000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
57000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
882000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68984000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-58000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34648000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52846000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47230000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100076000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47230000 usd
CY2023 nn Common Stock Issuedin Acquisitionof Business
CommonStockIssuedinAcquisitionofBusiness
usd
CY2022 nn Common Stock Issuedin Acquisitionof Business
CommonStockIssuedinAcquisitionofBusiness
13888000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
285000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
605000 usd
CY2023 nn Change In Value Of Class A Common Stock Subject To Possible Redemption
ChangeInValueOfClassACommonStockSubjectToPossibleRedemption
-1248000 usd
CY2022 nn Change In Value Of Class A Common Stock Subject To Possible Redemption
ChangeInValueOfClassACommonStockSubjectToPossibleRedemption
usd
CY2023 nn Issuance Of Warrants
IssuanceOfWarrants
22843000 usd
CY2022 nn Issuance Of Warrants
IssuanceOfWarrants
usd
CY2023 nn Interest Paid In Shares Including Capitalized Interest Operating And Investing Activities
InterestPaidInSharesIncludingCapitalizedInterestOperatingAndInvestingActivities
1888000 usd
CY2022 nn Interest Paid In Shares Including Capitalized Interest Operating And Investing Activities
InterestPaidInSharesIncludingCapitalizedInterestOperatingAndInvestingActivities
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1808000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
147000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71700000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-40100000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35400000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37100000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
85800000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <p class="highlightCont" style="font: 10pt Times New Roman, Times, Serif; margin: 0;"><span class="highlightCont" style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><i class="highlightCont">Use of Estimates</i></span></p> <p class="highlightCont" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24pt;"><span class="highlightCont" style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"> </span></p> </div> <p class="highlightCont" style="font: 10pt / 1.2 'Times New Roman', Times, serif; margin: 0px; text-indent: 24pt;"><span class="highlightCont" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; line-height: inherit;">In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period and accompanying notes. These estimates include those related to the useful lives and recoverability of long-lived and intangible assets, valuation of common stock warrants, income taxes and equity-based compensation, among others. NextNav bases estimates on historical experience, anticipated results and various other assumptions, including assumptions of future events, it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets, liabilities, equity, revenue and expenses, that are not readily apparent from other sources. Actual results and outcomes could differ materially from these estimates and assumptions.</span></p>
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1147000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
975000 usd
CY2023 us-gaap Costs Incurred Asset Retirement Obligation Incurred
CostsIncurredAssetRetirementObligationIncurred
164000 usd
CY2022 us-gaap Costs Incurred Asset Retirement Obligation Incurred
CostsIncurredAssetRetirementObligationIncurred
6000 usd
CY2023 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
37000 usd
CY2022 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
18000 usd
CY2023 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
128000 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
66000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
56000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1340000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1147000 usd
CY2023 us-gaap Development Costs
DevelopmentCosts
1000000 usd
CY2022 us-gaap Development Costs
DevelopmentCosts
600000 usd
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 item
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17493000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16317000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
580000 usd
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1176000 usd
CY2023 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-96000 usd
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
usd
CY2023Q4 us-gaap Goodwill
Goodwill
17977000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17493000 usd
CY2023 nn Indefinite Lived License Agreements With Federal Government Term
IndefiniteLivedLicenseAgreementsWithFederalGovernmentTerm
P10Y
CY2023 nn Business Acquisition Maximum Period For Measurement Of Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessAcquisitionMaximumPeriodForMeasurementOfRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
P1Y
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3862000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3926000 usd
CY2023 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2300000 usd
CY2022 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2200000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 nn Contract Liabilities
ContractLiabilities
300000 usd
CY2022 nn Contract Liabilities
ContractLiabilities
100000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2318000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2389000 usd
CY2023 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
6655000 usd
CY2022 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
6743000 usd
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
12865000 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
17369000 usd
CY2023 nn Total Stock Based Compensations Expense
TotalStockBasedCompensationsExpense
21838000 usd
CY2022 nn Total Stock Based Compensations Expense
TotalStockBasedCompensationsExpense
26501000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-71735000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-40116000 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107972000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107972000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101029000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2023 nn Antidilutive Securities Warrants
AntidilutiveSecuritiesWarrants
44268000 shares
CY2022 nn Antidilutive Securities Warrants
AntidilutiveSecuritiesWarrants
18750000 shares
CY2023 nn Antidilutive Securities Stock Options
AntidilutiveSecuritiesStockOptions
3641000 shares
CY2022 nn Antidilutive Securities Stock Options
AntidilutiveSecuritiesStockOptions
2293000 shares
CY2023Q4 nn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
4987000 shares
CY2022Q4 nn Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
2380000 shares
CY2023Q4 nn Unvested Restricted Stock Awards
UnvestedRestrictedStockAwards
334000 shares
CY2022Q4 nn Unvested Restricted Stock Awards
UnvestedRestrictedStockAwards
208000 shares
CY2023 nn Number Of Segment
NumberOfSegment
1 item
CY2023 nn Number Of Customers
NumberOfCustomers
2 item
CY2022 nn Number Of Customers
NumberOfCustomers
2 item
CY2023Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
9724000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
5971000 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
21561000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
22754000 usd
CY2023Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
3800000 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
3300000 usd
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
1700000 usd
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
3600 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13917000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3292000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10625000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12606000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2209000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10397000 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1100000 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
400000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1120000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1058000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
873000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
525000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
3582000 usd
CY2023Q4 nn Finite Lived Intangible Asset Expected Amortization
FiniteLivedIntangibleAssetExpectedAmortization
7158000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
4852000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
4126000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
154000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
107000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
363000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
232000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
4577000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
3899000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4252000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9598000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3760000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3474000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3182000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2427000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2214000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8476000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
23533000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5865000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17668000 usd
CY2023Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2300000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
107000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
279000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3913000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2420000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
324000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
387000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
583000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1772000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2434000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
6592000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5241000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3200000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
44267686 shares
CY2023 nn Warrants Issued
WarrantsIssued
7750530 shares
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023 nn Description Of Warrants
DescriptionOfWarrants
the right to redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last sales price of the Company’s common stock matched or exceeded $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which NextNav sends the notice of redemption to the warrant holders.
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7053000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4200000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2293000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.22
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4464000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1989000 shares
CY2023Q4 nn Share Based Compensation Arrangements By Share Based Payment Award Option Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionGrantsInPeriodWeightedAverageExercisePrice
3.01
CY2023 nn Aggregate Intrinsic Value Granted
AggregateIntrinsicValueGranted
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
379000 shares
CY2023 nn Share Based Compensation Arrangements By Share Based Payment Award Option Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionCancelledInPeriodWeightedAverageExercisePrice
3.46
CY2023 nn Aggregate Intrinsic Value Cancelled
AggregateIntrinsicValueCancelled
usd
CY2023 nn Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriod
2000 shares
CY2023 nn Share Based Compensation Arrangements By Share Based Payment Award Option Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionExpiredInPeriodWeightedAverageExercisePrice
0.28
CY2023Q4 us-gaap Share Price
SharePrice
4.45
CY2022Q4 us-gaap Share Price
SharePrice
2.93
CY2023Q4 nn Strike Price
StrikePrice
11.5
CY2022Q4 nn Strike Price
StrikePrice
11.5
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M25D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y9M25D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.669 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0405 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0413 pure
CY2023 nn Fair Value Of Warrantsin Dollars
FairValueOfWarrantsinDollars
0.91
CY2022 nn Fair Value Of Warrantsin Dollars
FairValueOfWarrantsinDollars
0.48
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4200000 usd
CY2023 nn Fair Value Adjustment Of Private Placement Warrants
FairValueAdjustmentOfPrivatePlacementWarrants
4101000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
1248000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7053000 usd
CY2023Q4 nn Capital Stock Shares Authorized
CapitalStockSharesAuthorized
600000000 shares
CY2023 nn Capital Stock Par Or Stated Value Per Share
CapitalStockParOrStatedValuePerShare
0.1000
CY2023 nn Common Stock Description
CommonStockDescription
(a) 500,000,000 shares of common stock and (b) 100,000,000 shares of undesignated preferred stock.
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111260257 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111132222 shares
CY2023 nn Aggregate Intrinsic Value Expired
AggregateIntrinsicValueExpired
usd
CY2023 nn Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gros
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGros
260000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.28
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3641000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.66
CY2023 nn Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P8Y1M17D
CY2023 nn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1
8388000 usd
CY2023 nn Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber1
1774000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.92
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5102000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1296000 shares
CY2022 nn Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice1
0.44
CY2022 nn Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2
P7Y7M20D
CY2022 nn Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue2
3357000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1897000 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.35
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y11M26D
CY2023 nn Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Aggregate Intrinsic Value Unvested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValueAggregateIntrinsicValueUnvested
2982000 usd
CY2022 nn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1
997000 shares
CY2022 nn Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1
4.52
CY2022 nn Weighted Average Remaining Contractual Termin Years1
WeightedAverageRemainingContractualTerminYears1
P8Y6M21D
CY2022 nn Aggregate Intrinsic Value Unvested1
AggregateIntrinsicValueUnvested1
1107000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3280000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
71845000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
40012000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
331000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-132000 usd
CY2023 nn Total Income Taxes
TotalIncomeTaxes
-71514000 usd
CY2022 nn Total Income Taxes
TotalIncomeTaxes
-40144000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
122000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
90000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
143000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
91000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
78000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-119000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
78000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-119000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.0123 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.1261 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0549 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0438 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.453 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3493 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0384 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0477 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.159 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0178 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0007 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35260000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19316000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1235000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
765000 usd
CY2023Q4 nn Basis In Underlying Investment
BasisInUnderlyingInvestment
82279000 usd
CY2022Q4 nn Basis In Underlying Investment
BasisInUnderlyingInvestment
70148000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3866000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
116000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
122640000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
90345000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121269000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
88874000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1371000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1471000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1371000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1497000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1371000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1497000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
26000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
121300000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000 usd
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000 usd

Files In Submission

Name View Source Status
0001213900-24-022183-index-headers.html Edgar Link pending
0001213900-24-022183-index.html Edgar Link pending
0001213900-24-022183.txt Edgar Link pending
0001213900-24-022183-xbrl.zip Edgar Link pending
ex1019_1.htm Edgar Link pending
ex1020_2.htm Edgar Link pending
ex1021_3.htm Edgar Link pending
ex211_4.htm Edgar Link pending
ex231_5.htm Edgar Link pending
ex311_6.htm Edgar Link pending
ex312_7.htm Edgar Link pending
ex321_8.htm Edgar Link pending
ex97_9.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img6738ddb335b146ce9958.jpg Edgar Link pending
img96b5dc944bea4e78ae91.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nn-20231231.htm Edgar Link pending
nn-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nn-20231231_cal.xml Edgar Link unprocessable
nn-20231231_def.xml Edgar Link unprocessable
nn-20231231_lab.xml Edgar Link unprocessable
nn-20231231_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nn-20231231_pre.xml Edgar Link unprocessable